๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines

โœ Scribed by Jory R. Baldridge; R.Thomas Crane

Book ID
115639060
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
49 KB
Volume
19
Category
Article
ISSN
1046-2023

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Safety evaluation of a new allergy vacci
Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPLยฎ) for the treatment of grass pollen allergy
โœ Paul Baldrick; Derek Richardson; Alan W. Wheeler; Stefan R. Woroniecki ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB

## Abstract A novel allergy vaccine (Pollinex^ยฎ^ Quattro) has been developed for the prevention or relief of allergic symptoms caused by a variety of pollens. Within this range, the grass pollen allergy vaccine contains extracts of 12 grass pollens and rye cereal (all chemically modi๏ฌed by glutaral

Pollinexยฎ Quattro Ragweed: safety evalua
Pollinexยฎ Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPLยฎ) for the treatment of ragweed pollen allergy
โœ Paul Baldrick; Derek Richardson; Stefan R. Woroniecki; Beverley Lees ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB

## Abstract A novel allergy vaccine (Pollinex^ยฎ^ Quattro Ragweed) has been developed for the prevention or relief of allergic symptoms caused by pollen from __Ambrosia__ spp. (ragweed). An extract from the pollen (chemically modified by glutaraldehyde) is adsorbed onto lโ€tyrosine with addition of t